Cargando…

Cutting-Edge Therapies and Novel Strategies for Acute Intermittent Porphyria: Step-by-Step towards the Solution

Acute intermittent porphyria (AIP) is an autosomal dominant disease caused by the hepatic deficiency of porphobilinogen deaminase (PBGD) and the slowdown of heme biosynthesis. AIP symptomatology includes life-threatening, acute neurovisceral or neuropsychiatric attacks manifesting in response to pre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Longo, Miriam, Paolini, Erika, Meroni, Marica, Dongiovanni, Paola
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8945550/ https://www.ncbi.nlm.nih.gov/pubmed/35327450 http://dx.doi.org/10.3390/biomedicines10030648

Ejemplares similares

α-Lipoic Acid Improves Hepatic Metabolic Dysfunctions in Acute Intermittent Porphyria: A Proof-of-Concept Study
por: Longo, Miriam, et al.
Publicado: (2021)

Remodeling of Mitochondrial Plasticity: The Key Switch from NAFLD/NASH to HCC
por: Longo, Miriam, et al.
Publicado: (2021)

The Role of Probiotics in Nonalcoholic Fatty Liver Disease: A New Insight into Therapeutic Strategies
por: Meroni, Marica, et al.
Publicado: (2019)

Acute intermittent porphyria
por: Syal, Kartik, et al.
Publicado: (2015)

Intermittent Acute Porphyria
por: Macleod, J. G., et al.
Publicado: (1953)

Alcohol or Gut Microbiota: Who Is the Guilty?
por: Meroni, Marica, et al.
Publicado: (2019)

Nutritional Interventions with Bacillus coagulans Improved Glucose Metabolism and Hyperinsulinemia in Mice with Acute Intermittent Porphyria
por: Longo, Miriam, et al.
Publicado: (2023)

Feigning Acute Intermittent Porphyria
por: Elkhatib, Rania, et al.
Publicado: (2014)

Genetic and Epigenetic Modifiers of Alcoholic Liver Disease
por: Meroni, Marica, et al.
Publicado: (2018)

Nutrition and Genetics in NAFLD: The Perfect Binomium
por: Meroni, Marica, et al.
Publicado: (2020)

Genetics Is of the Essence to Face NAFLD
por: Meroni, Marica, et al.
Publicado: (2021)

Expanding the phenotypic spectrum of non-alcoholic fatty liver disease and hypertriglyceridemia
por: Meroni, Marica, et al.
Publicado: (2022)

Self-efficacy and self-management strategies in acute intermittent porphyria
por: Hammersland, Marte H., et al.
Publicado: (2019)

Renal Failure Affects the Enzymatic Activities of the Three First Steps in Hepatic Heme Biosynthesis in the Acute Intermittent Porphyria Mouse
por: Unzu, Carmen, et al.
Publicado: (2012)

MBOAT7 down-regulation by genetic and environmental factors predisposes to MAFLD
por: Meroni, Marica, et al.
Publicado: (2020)

Cardiac calcification in acute intermittent porphyria
por: Ghatak, Tanmoy, et al.
Publicado: (2011)

Acute Intermittent Porphyria in Argentina: An Update
por: Cerbino, Gabriela Nora, et al.
Publicado: (2015)

Acute intermittent porphyria, givosiran, and homocysteine
por: Fontanellas, Antonio, et al.
Publicado: (2021)

Liver Transplantation for Acute Intermittent Porphyria
por: Lissing, Mattias, et al.
Publicado: (2021)

Mortality in Pedigrees with Acute Intermittent Porphyria
por: Neeleman, Rochus, et al.
Publicado: (2022)

The I148M PNPLA3 variant mitigates niacin beneficial effects: How the genetic screening in non-alcoholic fatty liver disease patients gains value
por: Paolini, Erika, et al.
Publicado: (2023)

The Non-Invasive Assessment of Circulating D-Loop and mt-ccf Levels Opens an Intriguing Spyhole into Novel Approaches for the Tricky Diagnosis of NASH
por: Paolini, Erika, et al.
Publicado: (2023)

Low Lipoprotein(a) Levels Predict Hepatic Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
por: Meroni, Marica, et al.
Publicado: (2021)

An update of clinical management of acute intermittent porphyria
por: Pischik, Elena, et al.
Publicado: (2015)

Acute Intermittent Porphyria: A Diagnostic Challenge
por: Vakili, Rahim, et al.
Publicado: (2016)

Effect of Menstrual Cycle on Acute Intermittent Porphyria
por: Júnior, V. R. Souza, et al.
Publicado: (2017)

Medical and financial burden of acute intermittent porphyria
por: Neeleman, Rochus A., et al.
Publicado: (2018)

Dental and Periodontal Health in Acute Intermittent Porphyria
por: Storjord, Elin, et al.
Publicado: (2022)

Biomarkers that predict attacks of acute intermittent porphyria
por: Takata, Tadayuki, et al.
Publicado: (2022)

Takotsubo Cardiomyopathy Triggered by Acute Intermittent Porphyria
por: Alzahrani, Talal
Publicado: (2023)

miRNA Signature in NAFLD: A Turning Point for a Non-Invasive Diagnosis
por: Dongiovanni, Paola, et al.
Publicado: (2018)

Genetics, Immunity and Nutrition Boost the Switching from NASH to HCC
por: Dongiovanni, Paola, et al.
Publicado: (2021)

An analysis of six cases of acute intermittent porphyria (AIP)
por: Ghosh, Soumitra, et al.
Publicado: (2006)

Acute intermittent porphyria: Diagnostic dilemma and treatment options
por: Kaur, Mohan Deep, et al.
Publicado: (2015)

Acute Intermittent Porphyria: A Diagnostic Challenge for Endocrinologist
por: Yuan, Tao, et al.
Publicado: (2015)

Acute intermittent porphyria after right hemi-colectomy()
por: Alshammary, Shadi, et al.
Publicado: (2017)

Acute intermittent porphyria: a test of clinical acumen
por: Dhital, Rashmi, et al.
Publicado: (2017)

Systematically Analyzing the Pathogenic Variations for Acute Intermittent Porphyria
por: Fu, Yibao, et al.
Publicado: (2019)

A Pharmacological Chaperone Therapy for Acute Intermittent Porphyria
por: Bustad, Helene J., et al.
Publicado: (2020)

Acute Intermittent Porphyria: Current Perspectives And Case Presentation
por: Spiritos, Zachary, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_0llbgmaein21h1c53va6i67ear